Treffer 1 - 3 von 3 für Suche 'Chayab, Lara*', Suchdauer: 0,79s Treffer weiter einschränken
  1. 1
    Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada

    Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inh... von Chayab, Lara, Leighl, Natasha B, Tadrous, Mina, Warren, Christine M, Wong, William W L

    Veröffentlicht in Current oncology (Toronto)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase

    A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase von Chayab, Lara, Konstantelos, Natalia, Leighl, Natasha B, Tadrous, Mina, Wong, William W. L

    Veröffentlicht in PharmacoEconomics

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

    A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NS... von Chayab, Lara, Konstantelos, Natalia, Leighl, Natasha B., Tadrous, Mina, Wong, William W. L.

    Veröffentlicht in PharmacoEconomics

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: